Cannabinoid CB1 receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca2+ influx in an in vitro model of diabetic neuropathy

Neuropharmacology

Volumn 57, Issue 2, 2009, Pages 88-96

  Zhang, Fan ^a   Challapalli, Sarat C ^a   Smith, Paula J W ^a  

^a EDINBURGH NAPIER UNIVERSITY   (United Kingdom)

Author keywords

Cannabinoid; CB1; Diabetic neuropathy; Glucose; PC12 cells; TRPV1

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 1 RECEPTOR; CAPSAICIN; DEXANABINOL; GLUCOSE; NERVE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG MECHANISM; GENE EXPRESSION; IN VITRO STUDY; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CAPSAICIN; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HYPERGLYCEMIA; INDOLES; NERVE GROWTH FACTOR; NEURITES; NEUROGENESIS; NEURONS; NEUROPROTECTIVE AGENTS; PC12 CELLS; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RNA, MESSENGER; SENSORY SYSTEM AGENTS; TETRAHYDROCANNABINOL;

EID: 67650167659     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.04.017     Document Type: Article

References (36)

1. Ahluwalia J., Urban L., Capogna M., Bevan S., and Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100 (2000) 685-688
2. Dagon Y., Avraham Y., Link G., Zolotarev O., Mechoulam R., and Berry E.M. The synthetic cannabinoid HU-210 attenuates neural damage in diabetic mice and hyperglycemic pheochromocytoma PC12 cells. Neurobiol. Dis. 27 (2007) 174-181
3. Derkinderen P., Valjent E., Toutant M., Corvol J.C., Enslen H., Ledent C., Trzaskos J., Caboche J., and Girault J.A. Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J. Neurosci. 23 (2003) 2371-2382
4. Dogrul A., Husamettin G., Yildiz O., Bilgin F., and Guzeldemir M.E. Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect. Neurosci. Lett. 368 (2004) 82-86
5. 1 receptor density in the hippocampus of streptozotocin-induced diabetic rats. Exp. Neurol. 204 (2007) 479-484
6. Engeli S., Bohnke J., Feldpausch M., Gorzelniak K., Janke J., Batkai S., Pacher P., Harvey-White J., Luft F.C., Sharma A.M., and Jordan J. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54 (2005) 2838-2843
7. Gasperi V., Fezza F., Pasquariello N., Bari M., Oddi S., Agrò A.F., and Maccarrone M. Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cell. Mol. Life Sci. 64 (2007) 219-229
8. Graham E.S., Ball N., Scotter E.L., Narayan P., Dragunow M., and Glass M. Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 281 (2006) 29085-29095
9. o/i-coupled cannabinoid receptor-mediated neurite outgrowth involves Rap regulation of Src and Stat3. J. Biol. Chem. 280 (2005) 33426-33434
10. 1 receptor-mediated response. Cell. Mol. Life Sci. 60 (2003) 607-616
11. Hong S., and Wiley J.W. Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. J. Biol. Chem. 280 (2005) 618-627
12. Jordan J.D., He J.C., Eungdamrong N.J., Gomes I., Ali W., Nguyen T., Bivona T.G., Philips M.R., Devi L.A., and Iyengar R. Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII. J. Biol. Chem. 280 (2005) 11413-11421
13. 1 receptor in thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol. 422 (2001) 83-86
14. Kennedy W.R., Navarro X., Sakuta M., Mandell H., Knox C.K., and Sutherland D.E. Physiological and clinical correlates of cardiorespiratory reflexes in diabetes mellitus. Diabetes Care 12 (1989) 399-408
15. Kilo S., Berghoff M., Hilz M., and Freeman R. Neural and endothelial control of the microcirculation in diabetic peripheral neuropathy. Neurology 54 (2000) 1246-1252
16. Lastres-Becker I., Fezza F., Cebeira M., Bisogno T., Ramos J.A., Milone A., Fernández-Ruiz J., and Di Marzo V. Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease. Neuroreport 12 (2001) 2125-2129
17. Lelkes E., Unsworth B.R., and Lelkes P.I. Reactive oxygen species, apoptosis and altered NGF-induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: an in vitro cellular model for diabetic neuropathy. Neurotox. Res. 3 (2001) 189-203
18. CT method. Methods 25 (2001) 402-408
19. Matias I., Gonthier M.P., Orlando P., Martiadis V., De Petrocellis L., Cervino C., Petrosino S., Hoareau L., Festy F., Pasquali R., Roche R., Maj M., Pagotto U., Monteleone P., and Di Marzo V. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J. Clin. Endocrinol. Metab. 91 (2006) 3171-3180
20. Millns P.J., Chapman V., and Kendall D.A. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. Br. J. Pharmacol. 132 (2001) 969-971
21. 1 receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem. Int. 40 (2002) 157-167
22. 1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 115 (2005) 1298-1305
23. Oshita K., Inoue A., Tang H.B., Nakata Y., Kawamoto M., and Yuge O. CB(1) cannabinoid receptor stimulation modulates transient receptor potential vanilloid receptor 1 activities in calcium influx and substance P release in cultured rat dorsal root ganglion cells. J. Pharmacol. Sci. 97 (2005) 377-385
24. Patwardhan A.M., Jeske N.A., Price T.J., Gamper N., Akopian A.N., and Hargreaves K.M. The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11393-11398
25. Rueda D., Navarro B., Martinez-Serrano A., Guzman M., and Galve-Roperh I. The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J. Biol. Chem. 277 (2002) 46645-46650
26. Said G. Diabetic neuropathy - a review. Nat. Clin. Pract. Neurol. 3 (2007) 331-340
27. Sarker K.P., Obara S., Nakata M., Kitajima I., and Maruyama I. Anandamide induces apoptosis of PC12 cells: involvement of superoxide and caspase-3. FEBS Lett. 472 (2000) 39-44
28. Sarker K.P., and Maruyama I. Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. Cell. Mol. Life Sci. 60 (2003) 1200-1208
29. Smith P.J.W., and McQueen D.S. Perivascular nerves induce cardiorespiratory reflexes in response to algogens in anaesthetized rats. Neurosci. Res. 50 (2004) 271-281
30. Someya A., Kunieda K., Akiyama N., HirabayashiHorie S., and Murayama T. Expression of vanilloid receptor in PC12 cells. Neurochem. Int. 45 (2004) 1005-1010
31. Ulugol A., Karadag C.H., Ipci Y., Tamer M., and Dokmeci I. The effect of WIN 55212-2, a cannabinoid agonist, on tactile allodynia in diabetic rats. Neurosci. Lett. 371 (2004) 167-170
32. Vinik A., Ullal J., Parson H.K., and Casellini C.M. Diabetic neuropathies: clinical manifestations and current treatment options. Nat. Clin. Pract. Endocrinol. Metab. 2 (2006) 269-281
33. Vossler M.R., Yao H., York R.D., Pan M.G., Rim C.S., and Stork P.J. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89 (1997) 73-82
34. Wu Y.Y., and Bradshaw R.A. Activation of the Stat3 signaling pathway is required for differentiation by interleukin-6 in PC12-E2 cells. J. Biol. Chem. 275 (2000) 2147-2156
35. Yan Z.C., Liu D.Y., Zhang L.L., Shen C.Y., Ma Q.L., Cao T.B., Wang L.J., Nie H., Zidek W., Tepel M., and Zhu Z.M. Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta. Biochem. Biophys. Res. Commun. 354 (2007) 427-433
36. 1 receptors in models of diabetic neuropathy. J. Pharmacol. Exp. Ther. 323 (2007) 508-515